Table 4 Clinical and laboratory parameters for our patients at last follow-up
Case | Age at last follow-up | Height at last follow-up (cm, percentile) | Hematologic symptoms | CKD Stage at last follow-up | Age at ESKD (years) | Dialysis | Infection complications | Neurologic complications | Autoimmune diseases |
|---|---|---|---|---|---|---|---|---|---|
1 | 5 y 8 ma | 78, < 3rd | Leucopenia WBC 2.2 × 109/L, Evans syndrome, bone marrow failure | 1 | - | No | Mycoplasma pneumoniae pneumonia, Candida albicans sepsis, protracted EBV systemic infection, Enterococcus cloacae sepsis | Recurrent headaches, convulsions, cerebral ischemic events, triplegia with expressive aphasia | Yes |
2 | 17 y 9 m | 123, < 3rd | Leucopenia WBC 3.4 × 109/L | 5 | 6 | Yes | Recurrent herpes zoster skin infection, repeated peritoneal catheter exit site Pseudomonas aeruginosa and Staphylococccus aureus infections | No | No |
3 | 7 y 3 m | 80, < 3rd | Leucopenia WBC 3.0 × 109/L | 5 | 2.5 | Yes | No | Recurrent headaches, transient ischemic attacks presenting as right upper limb palsy and expressive aphasia | No |
4 | 7y | 86, < 3rd | Leucopenia WBC 2.4 × 109/L | 5 | 3.3 | Yes | Recurrent upper respiratory infections, aphthous stomatitis | Recurrent headaches, transient ischemic attacks, right upper limb palsy | No |
5 | 2 y 6 m | 74, < 3rd | Leucopenia WBC 3.4 × 109/L | 5 | 3.3 | Yes | Severe course of COVID-19 infection | No | No |